Skip to main content

Advertisement

Table 2 Clinical outcomes between study groups

From: Effect of 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride (Voluven®) on complications after subarachnoid hemorrhage: a retrospective analysis

  Non HES group (n=72) HES group (n=57) Odds ratio (95%CI) p value
Primary outcome 10 (13.8%) 19 (33.3%) 3.1 (1.30-7.36) 0.01
Rebleeding 4 (5.6%) 0 (0%) 0.54 (0.46-0.64) 0.13
HCP requiring CSF shunting 3 (4.2%) 12 (21%) 6.1 (1.63-22.95) 0.004
Delayed cerebral ischemia 5 (6.9%) 10 (17.5%) 2.86 (0.91-8.88) 0.09
  1. Data reported as count (%).
  2. HCP Hydrocephalous.
  3. CSF Cerebrospinal fluid.
  4. CI Confidence interval.